Abstract
A putative tumor suppressor gene involved in B cell chronic lymphocytic leukemia (B-CLL) was mapped to human chromosome 13q14.3 close to the genetic markers D13S25 and D13S319. We constructed a 780-kb-long contig composed of cosmids, bacterial artificial chromosomes, and bacteriophage P1-derived artificial chromosomes that provides essential information and tools for the positional cloning of this gene. The conting contains both flanking markers as well as several additional genetic markers, three ESTs, and one potential CpG island. In addition, using one B-CLL patient, we characterized a small internal deleted region of 550 kb. Comparing this deletion with other recently published deletions narrows the minimally deleted area to less than 100 kb in our physical map. This deletion core region should contain all or part of the disrupted in B cell malignancies tumor suppressor gene.
References
Jun 1, 1992·Genes, Chromosomes & Cancer·L C PetersonN E Kay
Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·H ShizuyaM Simon
Apr 1, 1990·Cancer Genetics and Cytogenetics·G Juliusson, G Gahrton
Feb 1, 1990·Genomics·G M FordA J Becker
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D L NelsonC T Caskey
Dec 1, 1984·Cancer Genetics and Cytogenetics·M LalandeS A Latt
Jul 1, 1983·Analytical Biochemistry·A P Feinberg, B Vogelstein
May 1, 1984·Cell·D C Schwartz, C R Cantor
Jan 20, 1995·Analytical Biochemistry·L K AshworthM A Batzer
Feb 3, 1994·Nature·G Zehetner, H Lehrach
Jan 1, 1994·Nature Genetics·P A IoannouP J de Jong
Dec 1, 1993·Nature Genetics·K PetrukhinJ J Russo
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·Y LiuS Einhorn
Jan 1, 1993·Nature Genetics·A G BrownE M Weir-Thompson
Mar 14, 1996·Nature·C DibJ Weissenbach
Jun 15, 1997·Genomics·S KalachikovS G Fischer
Citations
Sep 1, 2001·British Journal of Haematology·V Brito-BabapulleD Catovsky
Aug 7, 2001·Reviews in Clinical and Experimental Hematology·S StilgenbauerH Döhner
Sep 6, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Peter OuilletteSami N Malek
Nov 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·George Adrian CalinCarlo M Croce
Jan 7, 2004·FEBS Letters·Marianne HammarsundDan Grandér
Mar 26, 2003·FEBS Letters·D V IvanovA V Baranova
Apr 25, 2007·Cancer Genetics and Cytogenetics·Stephanie StruskiMichel Lessard
Jan 20, 2000·Baillière's Clinical Haematology·A J BenchA R Green
Aug 25, 2004·Hematology/oncology Clinics of North America·Stephan Stilgenbauer, Hartmut Döhner
Oct 13, 2001·Genomics·C ChenJ T Dong
Dec 4, 2002·Genes, Chromosomes & Cancer·Manal O ElnenaeiDaniel Catovsky
Mar 10, 2001·Leukemia·H CavéB Grandchamp
Jun 22, 2001·Leukemia·R FonsecaG W Dewald
Jun 1, 2002·Leukemia·S StilgenbauerUNKNOWN German CLL Study Group (GCLLSG). Chronic lymphocytic leukemia
Jul 3, 2002·Leukemia·C RowntreeL Foroni
Oct 19, 2006·Blood·David NgJorge R Toro
May 16, 2002·Blood·Daniel MertensPeter Lichter
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jane HouldsworthR S K Chaganti
Apr 20, 2004·Blood·Holger KohlhammerMartin Bentz
Mar 27, 2001·Blood·A MigliazzaR Dalla-Favera
Dec 29, 2000·Oncogene·E KitamuraJ K Cowell
Jul 10, 1999·Current Opinion in Hematology·W G Wierda, T J Kipps
Nov 10, 2000·International Journal of Cancer. Journal International Du Cancer·D MertensP Lichter
Feb 19, 2008·Cancer Research·Peter OuilletteSami N Malek